Build your strategy on real patients,
not assumptions.

Thousands of AI-moderated interviews with patients, structured into live journeys, segments, and switching signals your commercial team can act on.

Take the platform tour →
40,000+ diagnosed patients  ·  30+ indications  ·  14 markets  ·  used by 6 of the top 20 global life science companies
Built for life science teams

mama health: one source of patient truth

Whether you're sizing a launch, briefing the medical leads, or sharpening a campaign — every team works from the same primary data, structured for their specific decision.

For Commercial Teams
// LAUNCH SIGNALLIVE
+22%
↗ revenue lift · 2 quarters
Illustrative

Optimize launches on real patient behavior.

Understand why patients switch, delay, or drop off — not just that they do. Primary patient conversations surface the behavioral reasons behind every market signal, giving your commercial team the context to act, not just react.

See how Commercial uses mama health For Medical Affairs
// PATIENT-REPORTED SIGNAL
Misdiagnosis · eczema → psoriasis28%
Time to confirmed diagnosis8.2mo
Unaddressed in HCP visit71%
Adherence drop · cycle 334%

Evidence the experience trial data doesn't capture.

RWE pipelines tell you what was prescribed and billed. They don't tell you why patients stopped, or what they wished their physician had asked. mama health structures all of it — ready for evidence dossiers and advisory boards.

See how Medical Affairs uses mama health For Marketing Teams
// MESSAGE RESONANCEN=3.2K
Concept A+78
Concept B+54
Concept C+32

Test messaging on the people it's for.

Brand teams test concepts on synthetic audiences and HCP panels — and find out months later that patients heard something different. Close the loop in days. Ranked benchmarks against real cohorts.

See how Marketing uses mama health
Customer voices

Don't just take our word for it.

Hold on! Please go back to the previous tab, I need to screenshot this. I have a launch review meeting later today and I want to discuss it with the medical director.

Marketing and Launch LeadGlobal Pharma
Global Pharma

Every chart is answering a question I didn't think was answerable.

Insights & Analytics LeadTop 10 Pharma
Top 10 Pharma

I have been hypothesizing that access to biopsy was not the main reason for a delayed diagnosis, but I could never prove it till now. With this info I am going to go after the real issue.

Medical Affairs DirectorTop 20 Pharma
Top 20 Pharma

We have been trying to bridge this gap of patient voices for 2 years and nobody could show it to us this clearly.

Patient Advocacy DirectorTop 20 Pharma
Top 20 Pharma

All the market leaders want to see the results. Can you join our global launch call next week and present?

Digital, Data & Technology Global DirectorTop 10 Pharma
Top 10 Pharma
Read all customer stories →
Disease-specific intelligence

Where launch plans meet patient reality.

Pressure-test every component of your commercial plan against the patient barriers your forecast missed — before they show up in claims data.

// Personas
Personas
who am i actually launching to?
Real patient stories clustered into actionable personas — drivers, barriers, activation levers.
// Adherence by cycle
Adherence
where will i lose patients in year one?
Where patients drop off, reconsider, or switch — surfaced as it happens.
// Top denial drivers
78
54
41
28
Access
which payer barriers will stall my ramp?
Coverage friction, prior-auth fatigue, and denial drivers from real patient experience.
// Referral routing
Pathway
who controls the referral to my drug?
How patients move between PCP, specialist, and care team — with the gaps mapped.
// Need clusters
Needs
which unmet need can my message own?
Functional and emotional gaps in the patient experience, ranked and clustered.
Behind the dashboard

How patient stories become signal.

Four steps, all run by us — from the right patients to live insight in your dashboard.

Step 01

Sourced.

patients recruited direct-to-consumer, condition verified at intake.

Step 02

Heard.

30–60 min AI-moderated interviews, clinician-reviewed protocol.

Step 03

Structured.

structured to a clinical taxonomy. anonymised, gdpr/hipaa-aligned, adverse events flagged for pv handoff.

Step 04

Delivered.

refreshed weekly as new patients come in.

40,000+ patients 15+ markets GDPR & HIPAA aligned Medically supervised
The platform

What the dashboard shows.

Built on patient conversations and updated continuously as new patients come in. One workspace, four primary views — every team works from the same primary signal.

analytics.mamahealth.com
mama health analytics dashboard showing patient journey, persona profiling, and switching trigger detection

Patient Journey View

End-to-end pathway from first symptom to ongoing care, annotated with friction points and unmet needs at every step.

Patient Clusters 3,280 pts
The Anxious Avoider
42%
The Active Searcher
31%
The Biologic-Ready
27%

Persona Profiling

Real patient stories clustered into actionable personas — each with its own drivers, barriers, and activation levers.

▷ Why are biologic-naive psoriasis patients in the southeast hesitant about injectables?
Fear of needles Side effects Cost concern Dr. scepticism Prefer oral

Ask AI

Ask detailed questions of your patient cohort in natural language. Explore the full dataset, generate charts, and surface insights — without writing a query or pulling a CSV.

LIVE SIGNALS
24 detections today
Re-evaluation intent · Plaque psoriasis · IL-17 switch
2m ago
Treatment dissatisfaction · RA · TNF escalation
11m ago
New diagnosis · Axial SpA · biologic-naive
34m ago

Real-Time Signalling

Proprietary signal detection identifies moments of treatment re-evaluation or switch intent within live patient conversations, surfaced to partners as it happens.

Case studies & insights

How teams put patient signal to work.

Stories, perspectives, and methods from life science teams using mama health to change how they launch, position, and decide.

View all articles →
Customer story · Top-20 biopharma Top-20 biopharma commercial team scaling patient intelligence from a single-market pilot to 11 markets

from a single-market pilot to 11 markets — in a category they had never marketed in.

A top-20 biopharma was launching two new therapies into a rare neuromuscular condition the team had never marketed in. A pilot ran first in one market. The engagement has scaled to a multi-market contract spanning 11 countries.

Read the story →

How real-time patient insights are changing pharma strategy.

Real-time patient insights changing pharma commercial strategy

Why 60% of commercial drug launches fail — and how to avoid the common mistakes.

Why 60% of commercial drug launches fail — pharmaceutical launch strategy insights

How real-world patient journey mapping is transforming healthcare insights.
The other side of the platform

Every insight starts with a real patient, being heard.

people living with chronic and rare conditions use mama health every day to make sense of their condition. they tell us things they wouldn't tell a market research panel — that's where the depth in your dashboard comes from.

See the patient experience
Coverage

Diseases and markets we cover.

From common chronic conditions to rare and complex diseases — here's a snapshot of where we have live patient communities today.

// Active markets 🇺🇸 🇩🇪 🇮🇹 🇫🇷 🇪🇸 🇬🇧 🇳🇱 🇨🇭 🇦🇹 🇵🇱 🇸🇰 🇵🇹 🇬🇷 🇯🇵
Neurology
Multiple SclerosisMyasthenia GravisMajor Depressive Disorder
Dermatology
Chronic Spontaneous UrticariaHand EczemaAtopic DermatitisPsoriasis
Endocrinology
Graves DiseaseThyroid Eye Disease
Respiratory
Pulmonary FibrosisCOPD
Rheumatology / Immunology
Lupus
Cardiology
Heart Failure
Nephrology
IgA Nephropathy
Gastroenterology
Inflammatory Bowel Disease
Hepatology
Decompensated Cirrhosis
Oncology
Prostate Cancer
Women's Health
Endometriosis
Sleep
Insomnia
Don't see your indication?   New cohorts spin up in weeks. Tell us what you need →

Clinical data wins trials.
Patient data wins markets.